Full-Time
Research Associate I/II
CRISPR Delivery Engineering
Posted on 3/7/2024
Develops CRISPR-based genetic medicine platforms
Compensation Overview
$68,000 - $90,000Annually
Junior
Alameda, CA, USA
- A BS/BA in Bioengineering, Cell or Molecular Biology, Synthetic Biology, or related discipline
- 2+ years wet lab research experience required
- Experience with mammalian cell and bacterial culture, molecular cloning and common bioassays required
- Expertise in use of mammalian cell reporter systems, screening in human cells, and readout by FACS and NGS analysis is a plus
- Experience with CRISPR-Cas gene editing systems and AAV transductions desired
- Ability to work collaboratively in a fast-paced, interdisciplinary research team
- Demonstrated quantitative and scientific thinker as evidenced by a strong publication record
- Excellent prioritization and organization skills
- Work closely with AAV engineering leads to creatively design, rapidly build, and efficiently screen AAV vectors for the controllable delivery of genome editing tools to target human cells and tissues
- As part of the screening projects, they will be responsible for cloning and producing high quality plasmids for AAV production, and the in vitro testing of AAV vectors in a variety of target cell lines
- Design and execute hypothesis-driven and properly controlled studies, analyze data with rigorous statistics, and write up publication quality reports
- Effectively collaborate with members within a fully integrated team to facilitate execution on projects within established timelines
- Effectively present updates, and communicate research plans and timelines to the senior leadership team
- Foster a driven, fast-paced, dynamic, and fun environment in which to do rigorous science
Scribe Therapeutics is engaged in pioneering advancements in genetic medicine, utilizing CRISPR-based technologies aimed at precise genome editing and specific targeting. Their focus on innovative delivery technologies and commitment to achieving exceptional specificity within the genome positions them as a leader in the biotechnology field. This commitment to cutting-edge science and precise therapeutic impacts offers a stimulating environment for professionals passionate about genetic research and development.
Company Stage
Series B
Total Funding
$140.2M
Headquarters
Alameda, California
Founded
2017